A red yeast rice-olive extract supplement reduces biomarkers of oxidative stress, OxLDL and Lp-PLA2, in subjects with metabolic syndrome: a randomised, double-blind, placebo-controlled trial.
Nina HermansAnastasia Van der AuweraAnnelies BreynaertAnnelies VerlaetTess De BruyneLuc Van GaalLuc PietersVeronique VerhoevenPublished in: Trials (2017)
ClinicalTrials.gov identifier: NCT02065180 . Registered on 13 February 2014.
Keyphrases
- double blind
- oxidative stress
- metabolic syndrome
- placebo controlled
- clinical trial
- diabetic rats
- dna damage
- saccharomyces cerevisiae
- ischemia reperfusion injury
- study protocol
- insulin resistance
- induced apoptosis
- phase iii
- uric acid
- phase ii
- cardiovascular risk factors
- cell wall
- open label
- anti inflammatory
- skeletal muscle
- randomized controlled trial
- signaling pathway